Cargando…

p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions

α-Synuclein is the main component of Lewy bodies, the intraneuronal inclusion bodies characteristic of Parkinson’s disease. Although α-synuclein accumulation is caused by inhibition of proteasome and autophagy-lysosome, the degradation of α-synuclein inclusions is still unknown. Formation of Lewy bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Yoshihisa, Tatebe, Harutsugu, Taguchi, Katsutoshi, Endo, Yasuhisa, Tokuda, Takahiko, Mizuno, Toshiki, Nakagawa, Masanori, Tanaka, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534125/ https://www.ncbi.nlm.nih.gov/pubmed/23300799 http://dx.doi.org/10.1371/journal.pone.0052868

Ejemplares similares

Differential Expression of Alpha-Synuclein in Hippocampal Neurons
por: Taguchi, Katsutoshi, et al.
Publicado: (2014)

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
por: Ishii, Ryotaro, et al.
Publicado: (2015)

HSF1 stress response pathway regulates autophagy receptor SQSTM1/p62-associated proteostasis
por: Watanabe, Yoshihisa, et al.
Publicado: (2016)

Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy
por: Kasai, Takashi, et al.
Publicado: (2016)

Diagnostic Value of Muscle [(11)C] PIB-PET in Inclusion Body Myositis
por: Noto, Yu-ichi, et al.
Publicado: (2020)

Increased levels of plasma total tau in adult Down syndrome
por: Kasai, Takashi, et al.
Publicado: (2017)

Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018)

Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021)

Association of p62/SQSTM1 Excess and Oral Carcinogenesis
por: Inui, Takuma, et al.
Publicado: (2013)

Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
por: Shinomoto, Makiko, et al.
Publicado: (2019)

ZZ-dependent regulation of p62/SQSTM1 in autophagy
por: Zhang, Yi, et al.
Publicado: (2018)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Expression of α-synuclein is regulated in a neuronal cell type-dependent manner
por: Taguchi, Katsutoshi, et al.
Publicado: (2018)

p62/SQSTM1 synergizes with autophagy for tumor growth in vivo
por: Wei, Huijun, et al.
Publicado: (2014)

Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
por: Kasai, Takashi, et al.
Publicado: (2019)

The higher-order molecular organization of p62/SQSTM1
por: Johansen, Terje, et al.
Publicado: (2015)

p62/Sqstm1 rescue in muscle retards the progression of steatohepatitis in p62/Sqstm1-null mice fed a high-fat diet
por: Miura, Ikuru, et al.
Publicado: (2022)

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
por: Tatebe, Harutsugu, et al.
Publicado: (2017)

Mutations in the β-amyloid precursor protein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models
por: Ohshima, Yoichi, et al.
Publicado: (2018)

Gender difference in development of steatohepatitis in p62/Sqstm1 and Nrf2 double-knockout mice
por: Watahiki, Takahisa, et al.
Publicado: (2020)

Autophagy mediates epithelial cancer chemoresistance by reducing p62/SQSTM1 accumulation
por: Battista, R. Alessia, et al.
Publicado: (2018)

SQSTM1/p62 mediates crosstalk between autophagy and the UPS in DNA repair
por: Hewitt, Graeme, et al.
Publicado: (2016)

The adaptor protein p62/SQSTM1 in osteoclast signaling pathways
por: McManus, Stephen, et al.
Publicado: (2012)

p62/SQSTM1: ‘Jack of all trades’ in health and cancer
por: Sánchez‐Martín, Pablo, et al.
Publicado: (2018)

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
por: Kojima, Yuta, et al.
Publicado: (2021)

Degradation of the Tumor Suppressor PDCD4 Is Impaired by the Suppression of p62/SQSTM1 and Autophagy
por: Manirujjaman, M., et al.
Publicado: (2020)

Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging
por: Kumar, Anita V., et al.
Publicado: (2022)

Preconditioning Involves Selective Mitophagy Mediated by Parkin and p62/SQSTM1
por: Huang, Chengqun, et al.
Publicado: (2011)

p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria
por: Okatsu, Kei, et al.
Publicado: (2010)

Tissue Specific Induction of p62/Sqstm1 by Farnesoid X Receptor
por: Williams, Jessica A., et al.
Publicado: (2012)

p62/SQSTM1 but not LC3 is accumulated in sarcopenic muscle of mice
por: Sakuma, Kunihiro, et al.
Publicado: (2015)

SQSTM1/p62 Interacts with HDAC6 and Regulates Deacetylase Activity
por: Yan, Jin, et al.
Publicado: (2013)

p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis
por: Li, Si-Si, et al.
Publicado: (2017)

SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
por: Calvo-Garrido, Javier, et al.
Publicado: (2019)

Genetic and Molecular Evaluation of SQSTM1/p62 on the Neuropathologies of Alzheimer’s Disease
por: Dong, Wei, et al.
Publicado: (2022)

Trehalose induces SQSTM1/p62 expression and enhances lysosomal activity and antioxidative capacity in adipocytes
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Insights into degradation mechanism of N-end rule substrates by p62/SQSTM1 autophagy adapter
por: Kwon, Do Hoon, et al.
Publicado: (2018)

Phasing out the bad—How SQSTM1/p62 sequesters ubiquitinated proteins for degradation by autophagy
por: Zaffagnini, Gabriele, et al.
Publicado: (2018)

SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling
por: Hou, Bolin, et al.
Publicado: (2019)

Regulation of FN1 degradation by the p62/SQSTM1-dependent autophagy–lysosome pathway in HNSCC
por: Liu, Xinchen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lbiq78vjc9jga4quqqei8413lc